Reuters

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

NEW YORK, April 17 (Reuters) - A U.S. judge has ‌rejected Bayer's (BAYGn.DE), opens new tab request for an injunction to block Johnson & Johnson's (JNJ.N), opens new tab alleged false advertising that ...
MM&M

Judge denies Bayer’s request to block J&J’s ‘false advertising’ campaign for rival prostate cancer drug

Bayer requested a preliminary injunction over J&J’s Erleada marketing, arguing its headline survival claims rely on flawed real-world data, not clinical trials. The judge ruled that Bayer failed to ...
MM&M

Fresh off ruling in J&J case, Bayer’s Nubeqa ad runs afoul of FDA

After Bayer recently made a fuss over Johnson & Johnson’s advertising for a rival prostate cancer drug, the company is now on the receiving end of its own pharma marketing complaint. On Tuesday, the ...
AOL

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

NEW YORK, April 17 (Reuters) - A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that ‌its multibillion-dollar drug cuts the risk of ...
AOL

U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims

A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023. REUTERS/Brendan McDermid NEW YORK, April 17 ...